Hep C could be next target on Vancouver’s Downtown Eastside

B.C. set to take on new infectious disease while marking progress made on HIV/AIDS

AIDS expert Dr. Julio Montaner and B.C.’s Ministry of Health are planning to take on another infectious disease with potentially deadly consequences: hepatitis C.

Speaking at a news conference Tuesday on Vancouver’s Downtown Eastside – where an estimated 80 per cent of area drug users have hep C – Health Minister Terry Lake said publicly funded treatment is now restricted to people who already have considerable liver damage, but that could change.

“What Dr. Montaner is looking at is a targeted hep C program for core transmitters: people who are living a lifestyle that puts them at risk for re-transmitting,” said Lake. “That work will require help from the provincial government and we’re having discussions about that at the moment.”

Hepatitis C is a blood-borne infection and almost all new cases among B.C.’s estimated 80,000 carriers are among drug users who spread it by sharing needles or pipes. But a large untreated pool of hep C is found among baby boomers who contracted it decades ago, often through unhygienic medical and dental practises. Many are undiagnosed.

“As we expand treatment and as the cost of those drugs come down, we will reach further upstream and treat more people, and treat them earlier,” Lake explained.

“We’re looking forward to getting rid of hepatitis C as we’re doing for HIV,” Montaner said.

David Ramsay, a counsellor with the Vancouver Native Health Society, says many clients have been cured of hepatitis C in the past year through the latest medications. People who regularly drink alcohol aren’t candidates for treatment, however, because of the strain it adds to their already damaged livers.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below